These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 22840457)
1. Effect of Western medicine therapy assisted by Ginkgo biloba tablet on vascular cognitive impairment of none dementia. Zhang SJ; Xue ZY Asian Pac J Trop Med; 2012 Aug; 5(8):661-4. PubMed ID: 22840457 [TBL] [Abstract][Full Text] [Related]
2. Comparison of integrated traditional Chinese and western medicine therapy on vascular cognitive impairment with no dementia. Wang LP; Zhang XY; Liu N; Ma ZZ; Fang DS Genet Mol Res; 2015 May; 14(2):4896-902. PubMed ID: 25966264 [TBL] [Abstract][Full Text] [Related]
3. Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial. Gardner CD; Zehnder JL; Rigby AJ; Nicholus JR; Farquhar JW Blood Coagul Fibrinolysis; 2007 Dec; 18(8):787-93. PubMed ID: 17982321 [TBL] [Abstract][Full Text] [Related]
4. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial. Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y Stroke Vasc Neurol; 2017 Dec; 2(4):189-197. PubMed ID: 29507779 [TBL] [Abstract][Full Text] [Related]
5. The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES). Chen CL; Ikram K; Anqi Q; Yin WT; Chen A; Venketasubramanian N; Cerebrovasc Dis; 2013; 35 Suppl 1():23-9. PubMed ID: 23548916 [TBL] [Abstract][Full Text] [Related]
6. Polysomnographic abnormalities in patients with vascular cognitive impairment-no dementia. Jiang B; Ding C; Yao G; Yao C; Zhang Y; Ge J; Qiu E; Elia M; Ferri R Sleep Med; 2013 Nov; 14(11):1071-5. PubMed ID: 24051120 [TBL] [Abstract][Full Text] [Related]
7. [Effects of ginkgo biloba tablet in treating mild cognitive impairment]. Dong ZH; Zhang CY; Pu BH Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Sep; 32(9):1208-11. PubMed ID: 23185760 [TBL] [Abstract][Full Text] [Related]
8. The effects of educational background on Montreal Cognitive Assessment screening for vascular cognitive impairment, no dementia, caused by ischemic stroke. Wu Y; Wang M; Ren M; Xu W J Clin Neurosci; 2013 Oct; 20(10):1406-10. PubMed ID: 23891119 [TBL] [Abstract][Full Text] [Related]
9. The impact of drugs against dementia on cognition in aging and mild cognitive impairment. Ihl R Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S38-43. PubMed ID: 13130387 [TBL] [Abstract][Full Text] [Related]
10. Radix/rhizoma notoginseng extract (sanchitongtshu) for ischemic stroke: a randomized controlled study. He L; Chen X; Zhou M; Zhang D; Yang J; Yang M; Zhou D Phytomedicine; 2011 Apr; 18(6):437-42. PubMed ID: 21094030 [TBL] [Abstract][Full Text] [Related]
11. Safety and effectiveness of a traditional ginkgo fresh plant extract - results from a clinical trial. Bäurle P; Suter A; Wormstall H Forsch Komplementmed; 2009 Jun; 16(3):156-61. PubMed ID: 19657199 [TBL] [Abstract][Full Text] [Related]
12. Montreal cognitive assessment and analysis of related factors for cognitive impairment in patients with chronic cerebral circulation insufficiency. Zhang L; Dong W; Han J; Wang Z; Sun D; Ji X; Li M; Zhang B Int J Psychiatry Med; 2015; 50(3):257-70. PubMed ID: 26561273 [TBL] [Abstract][Full Text] [Related]
13. [Cognitive impairment in patients with diabetes mellitus type 2 and possibilities of its treatment]. Khaĭrullin IKh; Esin RG; Pozdniak AO Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):25-9. PubMed ID: 25403297 [TBL] [Abstract][Full Text] [Related]
14. [Drug combination characteristics of Shenxiong glucose injection in treating ischemic cerebrovascular disease in real world]. Wang GQ; Xie YM; Liu H; Zhang Y; Jia PP; Zhuang Y Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(14):2808-2813. PubMed ID: 29098842 [TBL] [Abstract][Full Text] [Related]
15. EEG in silent small vessel disease: sLORETA mapping reveals cortical sources of vascular cognitive impairment no dementia in the default mode network. Sheorajpanday RV; Marien P; Weeren AJ; Nagels G; Saerens J; van Putten MJ; De Deyn PP J Clin Neurophysiol; 2013 Apr; 30(2):178-87. PubMed ID: 23545769 [TBL] [Abstract][Full Text] [Related]
16. Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression. Belcaro G; Ippolito E; Dugall M; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Steigerwalt RD; Cesarone MR; Pellegrini L; Luzzi R; Corsi M Int Angiol; 2015 Apr; 34(2):150-7. PubMed ID: 25519846 [TBL] [Abstract][Full Text] [Related]
17. [Study on the efficacy of ginkgo biloba extract, magnesium and levo-arginine in the treatment of patients with 2d stage arteriopathies. A preliminary study]. Michelini S; Micci A; Failla A; Moneta G; Ottaviani A Minerva Cardioangiol; 1998 Sep; 46(9):319-20. PubMed ID: 10021862 [No Abstract] [Full Text] [Related]
18. [Treatment of cognitive and non-cognitive symptoms in cerebrovascular disease]. Litvinenko IV; Naumov KM; Odinak MM Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(4):35-40. PubMed ID: 24874315 [TBL] [Abstract][Full Text] [Related]
19. [Clinical research of early intervention of modified shuyu pill in vascular cognitive impairment no dementia]. Tan ZH; Lan HC; Yang Q; Chen J; Mao SP; Zha YF; Xiao SJ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jan; 33(1):27-30. PubMed ID: 23596781 [TBL] [Abstract][Full Text] [Related]
20. [Tanakan (EGb 761) in the therapy of mild cognitive impairment]. Iakhno NN; Zakharov VV; Lokshina AB; Gavrilova SI; Fedorova IaB; Gustov AV; Korshunova IuA; Dziak LA; Miziakina EV; Odinak MM; Emelin AIu; PilipenkoP I ; Vostrikova EV Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(12):41-6. PubMed ID: 17274394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]